Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Abingdon Health PLC ( (GB:ABDX) ) has shared an announcement.
Abingdon Health plc has announced the opening of its analytical laboratory at its Doncaster facilities, operated by its subsidiary Abingdon Analytical Ltd. This development is part of the company’s strategy to enhance its comprehensive CDMO services, offering critical support in regulatory technical file preparation required for product approvals. The investment of up to £1 million from recent fundraising efforts underpins this expansion, which strengthens their market position in lateral flow testing and adjacent sectors. This new capability is expected to enhance product development and regulatory processes, thereby benefiting stakeholders and illustrating the company’s growth and commitment to expanding its service offerings.
More about Abingdon Health PLC
Abingdon Health Group is a leading Medtech contract service provider that offers a wide range of services to an international clientele. The company’s CDMO division specializes in lateral flow product development, regulatory support, technology transfer, and manufacturing services, aiding clients in developing and commercializing new assays. Additionally, Abingdon provides regulatory services through its subsidiaries Compliance Solutions (Life Sciences) and IVDeology, assisting in the regulatory process across various markets. The company’s Abingdon Simply Test platform offers consumers a range of self-tests to manage their health, with products available online and through international distributors. Founded in 2008, Abingdon Health is headquartered in York, England.
YTD Price Performance: -31.82%
Average Trading Volume: 159,945
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £14.52M
Learn more about ABDX stock on TipRanks’ Stock Analysis page.
